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Abstract
Objective—We examined the associations of muscle area and radiodensity with adiponectin and 
leptin.
Methods—1944 participants enrolled in the Multi-Ethnic Study of Atherosclerosis underwent 
computed tomography to quantify body composition and measurements of adiponectin, leptin, 
interleukin-6, C-reactive protein, and resistin.
Results—The mean age and body mass index of participants was 64.7 years and 28.1 kg/m2, 
respectively, and 49% were female. With adjustment for age, gender, race/ethnicity, traditional 
cardiovascular disease risk factors, inflammatory biomarkers, physical activity, and sedentary 
behavior, a 1-standard deviation (SD) increment in total abdominal, stability, and locomotor 
muscle area was associated with a 19%, 17%, and 12% lower adiponectin level, respectively 
(p<0.01 for all) but not leptin (p>0.05). Muscle radiodensity was more robustly associated with 
adiponectin and leptin in the multivariable linear regression models. That is, with full adjustment 
for all covariates, a 1-SD increment in total abdominal, stability, and locomotor muscle 
radiodensity was associated with a 31%, 31%, and 18% lower adiponectin level (p<0.01 for all) 
and 6.7%, 4.6%, and 8.1% higher leptin level (p<0.05 for all), respectively.
Conclusions—Our data suggest that increases in muscle area and radiodensity may have 
positive impacts on chronic inflammation, and in turn, reduce the risk of cardiometabolic disease.
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Introduction
Obesity is a growing global public health problem and a major risk factor for both type 2 
diabetes and cardiovascular disease. It is well established that obesity is characterized by 
low-grade inflammation including elevated levels of pro-inflammatory cytokines and 
reduced levels of anti-inflammatory cytokines (1). Among these cytokines, adiponectin and 
leptin have emerged as important regulators of glucose and lipid metabolism in skeletal 
muscle, contributing to insulin sensitivity and reduced risk of metabolic and cardiovascular 
disease (1,2).
Adiponectin is an abundant protein derived primarily from adipose tissue and acts directly 
on skeletal muscle to increase fatty acid oxidation and glucose uptake, and decrease 
triglyceride content in skeletal muscle (2,3). Higher concentrations of adiponectin have been 
associated with both a reduced and higher risk of metabolic and cardiovascular disease (4,5). 
More recently, adiponectin has been positively associated with cachexia (4) and inversely 
associated with muscle fiber size (6) and strength (4,7,8) in healthy adults and heart failure 
patients.
Leptin is secreted by adipose and muscle tissue and plays an important role in energy 
balance and glucose homeostasis (9). In this regard, leptin increases fatty acid oxidation and 
stimulates intramuscular triglyceride hydrolysis in skeletal muscle (1,2). In addition, leptin 
has anabolic effects on skeletal muscle (9). For example, leptin treatment in mice increases 
skeletal muscle mass and decreases the expression of factors associated with atrophy (9,10).
While adiponectin and leptin have been studied extensively in relation to adiposity, little is 
known about the role of skeletal muscle mass and density on adiponectin and leptin. 
Notably, skeletal muscle radiodensity has emerged as an important marker of the quality of 
muscle, with a lower radiodensity indicating greater fat infiltration of the muscle (11,12). 
Therefore, the aim of this study was to examine the associations of skeletal muscle area and 
radiodensity with adiponectin and leptin in a multi-ethnic cohort, and to determine if the 
associations were independent of relevant covariates including abdominal visceral and 
subcutaneous fat. We hypothesized that skeletal muscle area and radiodensity would be 
negatively associated with adiponectin and positively associated with leptin, independent of 
relevant covariates.
Methods
Participants
The Multi-Ethnic Study of Atherosclerosis (MESA) is a longitudinal cohort study of the 
characteristics of subclinical cardiovascular disease and the risk factors that predict 
progression to clinically overt cardiovascular disease or progression of the subclinical 
disease in adults from six regions across the US. The overall design of the MESA study has 
been published (13). In brief, the cohort included a total of 6814 men and women aged 45–
84 years who were free from clinically apparent cardiovascular disease at the time of 
enrollment (July 2000 to August 2002). The racial/ethnic groups of participants included 
African American, Chinese American, Hispanic and non-Hispanic white. Participants who 
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were enrolled in the study returned for follow-up clinic visits approximately 2, 4, 6, and 10 
years after the baseline clinic visit.
At clinic visits 2 and 3 (from 2002 to 2005), a random subset of 1970 participants were 
enrolled in an ancillary study where abdominal computed tomography (CT) scans were 
obtained and subsequently used to quantify abdominal muscle area, muscle radiodensity, 
visceral adipose tissue and subcutaneous adipose tissue. Approximately half of the 
participants had their abdominal CT scan at visit 2 and the other half at visit 3. Participants 
who had complete data on muscle area, muscle radiodensity, adiponectin and leptin were 
included in the study. To make measurements contemporaneous, we used visit-matched data 
for each participant for all analyses. The MESA studies were approved by the Institutional 
Review Board of each study site and all participants provided written informed consent.
Data collection
At all study visits, standard questionnaires were used to obtain information on participant 
sociodemographics, ethnicity and health history. Cigarette smoking was defined as current, 
former, or never smoker. Height and weight were measured to the nearest 0.1 cm and 0.5 kg, 
respectively, with participants wearing minimal clothing and no shoes. Body mass index 
(BMI) was calculated as weight in kg divided by height in meters squared. Waist, at the level 
of the umbilicus, and hip circumferences were measured using a standard flexible, tension-
regulated tape measure. Blood pressure was measured with an automated monitor after 5 
minutes of seated rest, with the last two of three readings averaged and recorded (Dinamap 
Monitor Pro 100, GE Healthcare, Waukesha, WI). Each participant’s arm circumference was 
measured and selection of a proper cuff size was based on the guideline that the length of the 
inflatable bladder in the cuff should be at least 40% of the arm circumference. Hypertension 
was defined as systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mmHg 
or taking antihypertensive medication (14).
Sedentary Behavior and Physical Activity Assessment
At each clinic visit, participants self-reported their time spent engaged in sedentary behavior 
and physical activity using the Typical Week Physical Activity Survey (TWPAS). This 
survey was adapted from the Cross-Cultural Activity Participation Study (15) and designed 
to identify the frequency of and time spent in sedentary behavior and in various physical 
activities during a typical week in the previous month. Survey responses were quantified into 
minutes per week of sedentary behavior (sedentary behavior) and MET-minutes per week of 
moderate-to-vigorous physical activity defined as moderate and vigorous activities from all 
categories.
Laboratory
At each clinic visit, venous blood was collected after a 12-hour fast and shipped to the 
MESA central laboratory for analysis of total and HDL cholesterol, triglycerides, and 
glucose. Stored fasting blood samples from visits 2 or 3 were analyzed for insulin, C-
reactive protein (CRP), adiponectin, leptin, tumor necrosis factor-alpha (TNF-α), 
interleukin-6 (IL-6) and resistin. All biomarkers were measured using Bio-Rad Luminex 
flow cytometry (Millipore, Billerica, MA) at the laboratory for Clinical Biochemistry 
Vella et al. Page 3
Obesity (Silver Spring). Author manuscript; available in PMC 2018 December 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Research (University of Vermont, Burlington, VT). Average analytic coefficients of variation 
across several control samples ranged from 6.0% to 13.0%.
Dyslipidemia was defined as a total cholesterol/HDL-cholesterol ratio >5.0 or if the 
participant was taking medication to reduce cholesterol (16). Diabetes was defined as fasting 
glucose ≥ 126 mg·dL−1 or use of diabetes medication (17). Estimated glomerular filtration 
rate (eGFR) was calculated using the chronic kidney disease-Epi equation (18).
Computed Tomography (CT) Measurements
To determine abdominal body composition by computed tomography, electron-beam 
scanners (Imatron C-150, Imatron Inc., South San Francisco, CA) were used at 
Northwestern University and University of California, Los Angeles, with the following 
settings: collimation 3 mm, slice thickness 6 mm, reconstruction using 25 6-mm slices with 
35-cm field of view and normal kernel. Multidetector CT scanners (Sensation 64 [Siemens, 
Malvern, PA] and GE Lightspeed [GE Healthcare, Waukesha, WI], Siemens S4 Volume 
Zoom, and Siemens Sensation 16 [Siemens, Malvern, PA]) were used at Columbia 
University, Wake Forest University, and University of Minnesota, respectively. The specific 
scanning methodologies employed in the MESA study have been reported elsewhere (19). 
Abdominal slices from these scans were processed using MIPAV 4.1.2 software (National 
Institutes of Health, Bethesda, MD) that measured adipose tissue, skeletal muscle, and total 
tissue using a semi-automated method. Adipose tissue was identified as being between −190 
and −30 Hounsfield units (HU), whereas skeletal muscle tissue was identified as being 
between 0 and 100 HU (20). Radiodensities between 0 and −30 HU were labeled as 
undefined tissue type (21). Six transverse cross sectional slices were analyzed at the 
following spine levels: 2 at L2/L3, 2 at L3/L4 and 2 at L4/L5.
Using the pixel radiodensities, and the HU criteria provided above, adipose tissue and 
skeletal muscle areas were calculated for subcutaneous and visceral adipose tissue, as well 
as abdominal muscle groups using a single slice obtained at L4/L5. Bilateral oblique, rectus 
abdominus, paraspinus and psoas muscles were defined within their unique fascial planes. 
These muscles were grouped into muscles of stabilization (oblique, rectus abdominus, 
paraspinus muscles), muscles of locomotion (psoas muscle), and total abdominal muscle 
(oblique, rectus abdominus, paraspinus muscles, and psoas). For each muscle, area was 
determined by summing the number of pixels of 0 to 100 HU within that muscle’s 
corresponding fascial plane. Muscle radiodensity was the average HU measurement within 
the muscle’s distinct fascial plane for those with an HU value within the appropriate range 
(20). Subcutaneous adipose tissue was defined as the adipose tissue outside of the visceral 
cavity, not including the adipose tissue located within the muscular fascia. Visceral adipose 
tissue area was computed as the sum of the pixels of the appropriate HU range (−30 to −190 
HU) and within the visceral cavity. CT imaging was interpreted by staff who were blinded to 
participants’ clinical information. Inter and intra-rater reliability for total abdominal, 
subcutaneous, and visceral cavity areas were 0.99 for all measurements. Inter and intra-rater 
reliability for all muscle groups ranged from 0.93 to 0.98.
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Statistics
Analyses for this report were completed in 2017. Among the 1970 participants, 1944 had 
complete data on muscle area, muscle radiodensity and adiponectin or leptin. There were 
153 individuals who were missing values for adiponectin and the covariates, resulting in a 
final analytic sample of 1791 participants when adiponectin was the outcome in regression 
analyses. Similarly, there were 160 individuals who were missing values for leptin and the 
covariates, leaving a sample size of 1784 for these analyses. Characteristics of the 
population were summarized with mean and standard deviation (SD) for continuous 
variables and frequency and percentage of the study population for categorical variables. 
Skewed variables are presented as median with interquartile range. ANCOVA was used to 
determine the means of muscle area and radiodensity by quartiles of adiponectin and leptin, 
after adjusting for age, sex, and race/ethnicity. The ANCOVA was the first step in the 
analyses to determine if muscle area and radiodensity were different across the quartiles of 
adiponectin and leptin, while controlling for non-modifiable significant confounders.
To normalize the distribution, adiponectin and leptin were log-transformed and then linear 
regression analysis was used to determine the association between these variables and both 
muscle area and radiodensity in continuous and (per 1 SD increment) and categorical (i.e., 
quartiles) forms. The initial model (model 1) adjusted for age, sex, race/ethnicity, smoking, 
dyslipidemia, hypertension, coronary artery calcium (CAC), physical activity and sedentary 
behavior. Model 2 included model 1 plus C-reactive protein, interleukin-6 and adiponectin 
(in leptin analysis) or leptin (in adiponectin analysis). Model 3 included model 2 plus 
subcutaneous and visceral adiposity. All statistical analyses were conducted using Stata 
(Version 13; StataCorp) and a p-value <0.05 was used to determine statistical significance.
Results
Table 1 presents the characteristics of the study sample. The mean age was 64.7 years and 
49% were female. Forty percent of participants were non-Hispanic white, 21% were African 
American, 26% were Hispanic/Latino, and 13% were Chinese American. On average, 
participants were overweight, with a mean BMI and waist circumference of 28.1 kg·m−2 and 
98.3 cm, respectively. Thirty-one percent of participants had a BMI greater than 30 kg·m−2. 
Almost half (46%) of participants were never smokers, 40% were dyslipidemic, 61% were 
hypertensive, and 14% had diabetes mellitus. Over half (58%) of participants had CAC with 
a mean score of 178.5. Mean adiponectin and leptin levels were 20.7 μg/mL and 20.7 
ng/mL, respectively.
Muscle area and radiodensity by quartiles of leptin and adiponectin
The mean muscle area and radiodensity by quartile of adiponectin and leptin are provided in 
Table 2. With adjustment for age, sex, and race/ethnicity, the mean levels of total abdominal 
and stability muscle radiodensity decreased across increasing quartiles of adiponectin 
(p<0.01), whereas the decrease in locomotor muscle radiodensity was not significant 
(p=0.17). Somewhat similarly, total abdominal, stability and locomotor muscle radiodensity 
also decreased across increasing quartiles of leptin. Moreover, total abdominal, stabilization, 
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and locomotor muscle area also decreased across increasing quartiles of adiponectin 
(p<0.01). There were no differences in muscle area across quartiles of leptin.
Multivariable associations of muscle area and radiodensity with adiponectin and leptin
Multivariable linear regression models were constructed to determine the independent 
associations between muscle radiodensity and area and the adipokines (Table 3). With 
adjustment for age, sex, race/ethnicity, smoking, dyslipidemia, hypertension, CAC, physical 
activity and sedentary behavior (model 1), a 1-SD increment in total abdominal, stability, 
and locomotor muscle area was associated with a 24%, 22%, and 11% lower adiponectin 
levels, respectively (p < 0.01 for all). These associations were slightly attenuated but 
remained significant with the addition of all covariates including abdominal subcutaneous 
and visceral adipose tissue (model 3, 19%, 17%, and 13%, respectively, p < 0.01 for all). 
Muscle radiodensity was more robustly related to adiponectin in the multivariable linear 
regression models. That is, with adjustment for all covariates (model 3), a 1-SD increment in 
total abdominal, stability, and locomotor muscle radiodensity was associated with a 31%, 
31%, and 18% lower adiponectin level, respectively (p < 0.01 for all).
With adjustment for age, sex, race/ethnicity, smoking, dyslipidemia, hypertension, CAC, 
physical activity and sedentary behavior (model 1), a 1-SD increment in total abdominal, 
stability, and locomotor muscle radiodensity was associated with a 21%, 22%, and 13% 
lower leptin level, respectively (p<0.001 for all). Additional adjustments for C-reactive 
protein, interleukin-6, and adiponectin did not materially change the magnitude or 
significance of the associations. Notably, with the addition of subcutaneous and visceral 
adipose tissue (model 3) a 1-SD increment in total abdominal, stability, and locomotor 
muscle radiodensity was associated with a 6.7%, 4.6%, and 8.1% higher leptin level, 
respectively (p < 0.05 for all). Muscle area was not independently associated with leptin in 
any of the models (p>0.05).
The results of multivariable linear regression when muscle radiodensity and area were 
considered as categorical variables and divided into quartiles are provided in Figure 1 
(model 3 is presented). Compared with the lowest quartile, and after adjustment for age, sex, 
race/ethnicity, smoking, dyslipidemia, hypertension, CAC, physical activity, sedentary 
behavior and the other adipokines (model 2), there was a stepwise decrease in adiponectin 
with each higher quartile of total abdominal (9, 16, 29%, respectively) and stabilization (8, 
18, 29%, respectively) muscle area, as well as total abdominal (9, 21, 24%, respectively) and 
stabilization (10, 21, 26%, respectively) muscle radiodensity, which was maintained in the 
fully adjusted model (p<0.05 for all). After full adjustment and compared with the lowest 
quartile, the third and fourth quartiles of locomotor muscle radiodensity were associated 
with a 16% and 25%, respectively, lower adiponectin level (p<0.001).
Compared with the lowest quartile, and after adjustment for age, sex, race/ethnicity, 
smoking, dyslipidemia, hypertension, CAC, physical activity, sedentary behavior and the 
other adipokines (model 2) there was a stepwise decrease in leptin with each higher quartile 
of total abdominal (24, 40, 61%, respectively), stabilization (16, 34, 59%, respectively), and 
locomotor (26, 29, 28%, respectively) muscle radiodensity (p<0.001 for all). With additional 
adjustment for subcutaneous and visceral adipose tissue (model 3), and compared to the first 
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quartile, the second, third and fourth quartiles of stabilization muscle radiodensity were 
associated with a 12, 15, and 16% higher leptin level (p<0.05), whereas the third (12%) and 
fourth (18%) quartiles of total abdominal muscle radiodensity and the fourth quartile (20%) 
of locomotor muscle radiodensity were associated with higher leptin levels (p<0.05 for all). 
After full adjustment, and compared to the first quartile, the second, third and fourth 
quartiles of total abdominal muscle area were associated with a 14, 16, and 17% higher 
leptin level (p<0.05), whereas the second and third quartiles of stabilization muscle area 
were associated with 13 and 14% higher leptin level (p<0.05). Locomotor muscle area was 
not independently associated with leptin in any of the models (p>0.05).
Discussion
In this multiethnic cross-sectional analysis of older adults, higher levels of abdominal 
muscle radiodensity were associated with significantly lower levels of adiponectin and 
higher levels of leptin. Notably, these associations were independent of relevant covariates 
including subcutaneous and visceral adiposity, cardiovascular disease risk factors, and other 
markers of inflammation. Further, abdominal muscle area was independently associated with 
levels of adiponectin but not leptin. Overall, the associations of abdominal muscle 
radiodensity were more robust for adiponectin than leptin. These results suggest that 
decreased skeletal muscle area and radiodensity are independent risk factors for chronic 
inflammation and may contribute to an increased risk of cardiometabolic disease.
Little is known about the precise role of “muscle quality” on inflammatory cytokines. The 
robust association between muscle area and radiodensity with adiponectin in the current 
study are consistent with previous literature and suggest that adiponectin may be an 
important clinical marker for sarcopenia. Bucci et al. (8) compared 412 participants from the 
European research network study MYOAGE and reported that total adiponectin was 
inversely associated with quadriceps and handgrip strength in older but not younger adults. 
Similarly, population-based cohort studies have reported inverse associations between 
adiponectin and muscular strength, physical function, and disability in community-dwelling 
older adults (7,22,23). Our study extends the literature by investigating muscle area and 
radiodensity by CT scan, which provides information on “muscle quality”, as well as area.
It is well recognized that aging is associated with higher levels of adiponectin (8,23) despite 
the increase in visceral adiposity and insulin resistance that typically occurs with age (24). 
Adiponectin affects several metabolic processes involved in the control of energy 
homeostasis, by stimulating fatty acid oxidation and glucose uptake in skeletal muscle 
through AMP-activated protein kinase signaling (2,4). A dysregulation in adiponectin with 
age and/or obesity may blunt this process, reducing fat metabolism and increasing fat 
deposition within skeletal muscle, thereby reducing muscle density. The inverse association 
between muscle radiodensity and adiponectin demonstrated in our study provides further 
support for this hypothesis.
To date, several lines of evidence suggest a role for adiponectin in muscle morphology, with 
data from both human and animal models. In animal models, adiponectin knockout mice 
demonstrate a greater type IIb muscle fiber area when compared to wild-type controls. 
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Similarly, in in humans, inverse associations between adiponectin concentrations and muscle 
fiber size (6) and arm muscle mass as measured by dual-energy x-ray absorptiometry (25) 
have been reported. The inverse association between muscle area and adiponectin 
demonstrated in our study is consistent with these findings and provides additional evidence 
for a link between adiponectin and skeletal muscle morphology.
Importantly, our data show that the association between muscle radiodensity with leptin is 
positive when subcutaneous and visceral adiposity are accounted for in the model. 
Subcutaneous and visceral adipose tissue were negatively correlated with muscle 
radiodensity but positively correlated with leptin, indicating significant reverse confounding. 
Specifically, when subcutaneous and visceral adipose tissue were included in the model, the 
negative association between leptin and subcutaneous and visceral adipose tissue was 
accounted for (i.e., removed from the association between leptin and muscle radiodensity) 
and the association between leptin and muscle radiodensity changed from negative to 
positive. Further, the associations with leptin were stronger for muscle radiodensity than 
area. In mouse models leptin treatment is associated with increases in muscle mass and 
decreases the expression of factors associated with atrophy (10). One of the major 
physiological roles of leptin is suggested to be the prevention of lipid accumulation in 
peripheral tissues, including skeletal muscle (26). In this regard, higher leptin levels would 
limit the amount of lipid deposition in muscle, thereby maintaining a high radiodensity or 
quality of muscle.
Aging is associated with a progressive decline of muscle mass and quality, a condition 
termed sarcopenia. In addition, low muscle mass in aged individuals is associated with 
higher rates of disability and mortality (27). Therefore, understanding the factors associated 
with the age-related loss of skeletal muscle and function is of growing importance. Several 
proposed mechanisms for age-related muscle atrophy include physical inactivity, poor diet, 
oxidative stress, inflammation, and hormonal changes, with the mechanisms purported to be 
multifactorial (27). It is appreciated that both adiponectin and leptin affect several metabolic 
processes involved in the control of energy homeostasis, with increasing fatty acid oxidation 
in skeletal muscles one of the most important mechanisms by which insulin sensitivity is 
maintained. These findings also suggest that adiponectin and leptin may play an important 
role in skeletal muscle health. Skeletal muscle secretes myokines, including leptin (9) and 
adiponectin (4) that are thought to have endocrine, autocrine and paracrine effects. Thus, the 
amount and quality of skeletal muscle may play a protective role in inflammatory-related 
conditions, including obesity, insulin resistance, and cardiometabolic disease (28).
The strengths of the current study include a relatively large, well-characterized, multi-ethnic 
sample of men and women, the use of objective measures of abdominal muscle and adipose 
tissue via CT scan, careful assessment of many potentially confounding factors, and 
inflammatory markers that were analyzed at a central laboratory, with a high level of 
reproducibility. Nonetheless, our findings should be considered in the context of several 
limitations. First, measures of physical activity and sedentary behavior were self-reported 
and subject to recall bias. Second, this was a cross-sectional analyses and direction of 
associations cannot be determined. It is possible that adiponectin and leptin levels resulted in 
changes in muscle mass (i.e., reverse causation). Given this, prospective studies are needed 
Vella et al. Page 8
Obesity (Silver Spring). Author manuscript; available in PMC 2018 December 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
to determine relationships of muscle area and radiodensity with adiponectin and leptin over 
time. Third, although abdominal subcutaneous and visceral adipose tissue were included in 
this study, we did not assess intramuscular adipose tissue. Finally, the use of multiple CT 
scanners from different manufacturers to measure body composition may introduce bias; 
however, research suggests that electron beam and multi-detector row CT scanners that were 
used in this study have equivalent reproducibility, particularly for CAC measurements (29–
31). Mao et al. (31) reported a high degree of agreement (99%, 92%, and 92%) for presence 
of CAC, Agatston score and volume score, respectively, between electron beam and 
multidetector scanners. Further a study investigating between scanner variability for soft 
tissue reported a small mean difference and standard error in subcutaneous adipose tissue 
(−4.2 cm2 and 2.8%, respectively), visceral adipose tissue (−2.6 and 5.5%, respectively) and 
muscle tissue (1.8 cm2 and 1.9%, respectively) at L4 (32). Notably, all of the scans for our 
study were processed using the same software and inter and intra-rater reliabilities for total 
abdominal, subcutaneous, and visceral cavity areas were 0.99 for all measurements. Inter 
and intra-rater reliability for all muscle groups ranged from 0.93 to 0.98.
Conclusions
In summary, abdominal muscle radiodensity was inversely associated with adiponectin 
levels and positively associated with leptin levels, whereas abdominal muscle area was 
associated with levels of adiponectin but not leptin. These associations were independent of 
relevant covariates including physical activity, sedentary behavior, cardiovascular disease 
risk factors, central adiposity, and other markers of inflammation. Our data suggest that 
increasing total abdominal muscle area and radiodensity may have positive impacts on 
chronic inflammation, and in turn, reduce the risk of cardiometabolic disease.
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• Adiponectin and leptin have emerged as important regulators of metabolism 
in skeletal muscle, contributing to insulin sensitivity and muscle morphology.
• Few population-based studies have investigated associations between skeletal 
muscle and adipokines.
• We show muscle area and radiodensity are independently related to 
adiponectin and leptin.
• These associations were independent of relevant covariates including 
subcutaneous and visceral adipose tissue, which are both important 
contributors to levels of these adipokines.
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Figure 1. 
Multivariable-adjusted associations between quartiles of muscle area and radiodensity with 
levels of adiponectin (A) and leptin (B) for model 3.
Referent category: Quartile 1. Muscle area quartile cutpoints (cm2): total abdominal: 
Q1<77.01, Q2= 77.02–94.66, Q3=94.67–116.84, Q4≥116.85; stabilization: Q1<58.19, 
Q2=58.20–72.12, Q3=72.13–89.13, Q4≥89.14; locomotor: Q1<17.88, Q2=17.88–22.75, 
Q3=22.76–28.83, Q4≥28.84; Muscle radiodensity quartile cutpoints (HU): total abdominal: 
Q1<38.17, Q2=38.17–42.69, Q3=42.70–46.34, Q4≥46.35; stabilization: Q1<35.24, 
Q2=35.24–39.86, Q3=39.87–44.06, Q4≥44.07; locomotor: Q1<47.14, Q2=47.15–50.84, 
Q3=50.85–53.89; Q4≥53.90. Model 3 adjusted for age, sex, race/ethnicity, dyslipidemia, 
hypertension, diabetes, smoking, glomerular filtration rate, physical activity, sedentary 
behavior, adipokines, and subcutaneous and visceral adipose tissue. B=slope; SEE, standard 
error of the estimate; *p<0.05.
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Table 1
Characteristics of the study cohort: The Multi-Ethnic Study of Atherosclerosis.
Characteristic Men (n=983) Women (n=961) Total (n=1944)
Age (years, M [SD]) 64.3 (9.2) 65.1 (9.4) 64.7 (9.7)
Ethnicity (% [Freq])
 White 42.2 (415) 38.5 (370) 40.3 (785)
 Chinese American 13.5 (133) 12.3 (118) 12.9 (251)
 African American 18.4 (181) 23.5 (226) 20.9 (407)
 Hispanic 25.8 (254) 25.7 (247) 25.8 (501)
Ever Smoker (% [Freq]) 43.5 (428) 33.5 (322) 54.2 (1051)
BMI (M [SD]) 27.9 (4.4) 28.4 (5.0) 28.1 (5.2)
Dyslipidemia (% [Freq]) 43.5 (428) 33.5 (322) 39.6 (750)
Diabetes (% [Freq]) 16.1 (158) 12.6 (121) 14.4 (279)
Hypertension (% [Freq]) 60.6 (596) 61.1 (585) 60.9% (1181)
Coronary Artery Calcium (% [Freq]) 66.2 (651) 45.3 (435) 57.6 (1086)
Waist circumference (cm, M [SD]) 99.2 (12.0) 97.3 (15.8) 98.3 (14.1)
Subcutaneous fat area (cm2, M [SD]) 211.6 (95.0) 296.6 (122.9) 253.7 (117.7)
Visceral fat area (cm2, M [SD]) 164.1 (72.5) 131.8 (61.6) 148.0 (69.2)
Abdominal muscle area (cm2, M [SD]) 116.4 (23.9) 80.3 (17.4) 98.3 (27.6)
Stability muscle area (cm2, M [SD]) 87.3 (20.1) 62.0 (15.1) 74.6 (21.8)
Locomotor muscle area (cm2, M [SD]) 29.0 (6.1) 18.3 (3.8) 23.7 (7.4)
Abdominal muscle radiodensity (HU, M [SD]) 44.4 (4.9) 40.1 (5.2) 42.2 (5.5)
Stability muscle radiodensity (HU, M [SD]) 42.1 (5.4) 37.0 (5.7) 39.5 (6.1)
Locomotor muscle radiodensity (HU, M [SD]) 51.1 (5.0) 49.3 (5.3) 50.2 (5.2)
Sedentary Behavior (min·wk−1, Mdn [IQR]) 1421 (1260) 1560 (1511) 1470 (1451)
MVPA (MET-min·wk−1, Mdn [IQR]) 3983 (5320) 3229 (4025) 3555 (4538)
Systolic blood pressure (mmHg, M [SD]) 123 (9) 126 (23) 124 (21)
Diastolic blood pressure (mmHg, M [SD]) 73 (9) 67 (10) 70 (10)
Coronary artery calcium score (Mdn [IQR]) 33.7 (230.6) 0.0 (59.7) 8.9 (135.5)
Insulin (pmol·L−1) 294.3 (438.4) 285.8 (214.6) 290.1 (346.4)
Glucose (mg·dL−1, M [SD]) 100.0 (27.6) 96.9 (27.7) 98.3 (27.7)
Triglycerides (mg·dL−1, M [SD]) 135.0 (110.3) 132.2 (76.3) 133.6 (95.0)
High-density lipoprotein (mg·dL−1, M [SD]) 46.3 (12.4) 56.8 (15.9) 51.5 (15.1)
Low-density lipoprotein (mg·dL−1, M [SD]) 109.6 (31.1) 114.5 (31.5) 112.1 (31.4)
eGFR (mL·min−1, M [SD]) 79.7 (16.8) 78.6 (18.1) 79.2 (17.4)
C-reactive protein (mg·L−1, Mdn [IQR] 1.2 (1.8) 1.9 (3.4) 1.5 (2.6)
Adiponectin (μg·mL−1, Mdn [IQR]) 14.5 (10.9) 21.5 (16.6) 17.4 (14.5)
Leptin (ng·mL−1, Mdn [IQR]) 7.1 (10.8) 25.0 (29.8) 13.4 (22.7)
Resistin (ng·mL−1, Mdn [IQR]) 14.8 (6.8) 15.2 (7.6) 15.0 (7.2)
Interleukin-6 (pg·mL−1, Mdn [IQR]) 1.8 (1.6) 1.9 (1.7) 1.9 (1.7)
TNF-α (pg·mL−1, Mdn [IQR]) 4.8 (2.7) 4.5 (1.9) 4.6 (2.9)
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Note. M, mean; SD, standard deviation; %, percent; Freq, frequency; Mdn, median; IQR, interquartile range; BMI, body mass index; HU, 
Hounsfield units; MVPA, moderate-to-vigorous physical activity; MET, metabolic equivalents; eGFR, estimated glomular filtration rate; TNF-α, 
tumor necrosis factor alpha; waist circumference – at umbilicus level.
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